Law360 (March 18, 2011, 6:23 PM EDT) -- Generic-drug maker SigmaPharm Inc. on Friday appealed a Pennsylvania federal judge's dismissal of its antitrust and contract suit against Mutual Pharmaceutical Co. Inc. and King Pharmaceuticals Inc. over royalties for a potential generic version of muscle relaxant Skelaxin.
A notice of appeal was filed in the U.S. District Court for the Eastern District of Pennsylvania, a couple of weeks after Judge Cynthia M. Rufe threw out SigmaPharm's suit. The case is being appealed to the U.S. Court of Appeals for the Third Circuit.
SigmaPharm had a development agreement with Mutual and United Research Laboratories Inc., another defendant in the case, to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!